Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with hormone-dependent cancer.
-
Martin Lehr, Co-Founder and Chief Executive Officer, Context
Mr. Lehr is the Co-founder and CEO of Context Therapeutics. In addition, Mr. Lehr serves on the Boards of Praesidia Biologics and CureDuchenne Ventures. Previously, Martin was part of the founding team at Osage University Partners, a venture capital fund focused on academic spinouts from leading research institutions. Prior to Osage, Martin conducted research at the Sloan Kettering Institute in DNA repair and at the Children’s Hospital of Philadelphia in thrombosis and hemostasis. Martin is a Director of BioBreak, a biotech executive peer networking group with over 2,500 active members across the United States, and an Advisory Board Member of Life Science Cares and Life Science Leader magazine. Mr. Lehr holds an M.A. in Biotechnology from Columbia University and a B.A. in Economics from the University of Pennsylvania.
